Items where Author is "Marsh, Ryan"
Up a level |
Group by: Item Type | No Grouping
Number of items: 3.
Marsh, Ryan ORCID: https://orcid.org/0000-0002-3790-1721, Dos Santos, Claudio ORCID: https://orcid.org/0000-0003-0144-4327, Yule, Alexander ORCID: https://orcid.org/0000-0002-2666-2673, Dellschaft, Neele S ORCID: https://orcid.org/0000-0001-5483-1684, Hoad, Caroline L ORCID: https://orcid.org/0000-0001-5483-1027, Ng, Christabella ORCID: https://orcid.org/0000-0001-7243-3014, Major, Giles ORCID: https://orcid.org/0000-0001-7944-3709, Smyth, Alan R ORCID: https://orcid.org/0000-0001-5494-5438, Rivett, Damian ORCID: https://orcid.org/0000-0002-1852-6137 and van der Gast, Christopher ORCID: https://orcid.org/0000-0003-1101-4048
(2024)
Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis.
Journal of Cystic Fibrosis, 23 (5).
pp. 967-976.
ISSN 1569-1993
Marsh, Ryan (2024) The organisation and function of the gut microbiota in cystic fibrosis. Doctoral thesis (PhD), Manchester Metropolitan University.
Marsh, Ryan, Dos Santos, Claudio, Hanson, Liam, Ng, Christabella, Major, Giles, Smyth, Alan R, Rivett, Damian ORCID: https://orcid.org/0000-0002-1852-6137 and van der Gast, Christopher ORCID: https://orcid.org/0000-0003-1101-4048
(2023)
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Microbiology Spectrum, 11 (5).
ISSN 2165-0497